Kenvue is expected to announce its third-quarter results by early November, and analysts expect a notable decline in earnings ...

For over a decade, and as recently as August, FDA has fully evaluated the emerging scientific evidence and repeatedly ...

“For over a decade — and as recently as August — FDA has fully evaluated the emerging scientific evidence and repeatedly ...

Kenvue, the maker of Tylenol, is urging U.S. health regulators not to add an autism warning label to it and other ...

Kenvue, the maker of Tylenol, opposes proposed changes to the product's safety label regarding potential links to autism and ...

Hyderabad paediatrician Dr Sivaranjani Santosh sharply criticised FSSAI for permitting disposal of high-sugar ORSL stocks.

In today’s Pharmaceutical Executive Daily, we cover major leadership changes at Novo Nordisk, Kenvue’s request for the FDA to ...

Perimenopausal women who used estrogen for at least 10 years before their periods stopped had 60% lower odds for breast ...

Valued at $10.7 billion by market cap, Moderna, Inc. (MRNA) is a biotechnology company specializing in the development and ...

Johnson & Johnson stopped selling its talc-based baby powder in the US and Canada in 2020. In 2023, it switched to a cornstarch formula. The company maintains its baby powder is safe. Its consumer ...

Houston, Texas-based EOG Resources, Inc. (EOG) explores, produces, and markets crude oil, natural gas liquids, and natural ...

This segment is sponsored by Kenvue Brands. More than 30 million Americans are enrolled in Medicare Advantage, yet billions ...